Use of FLT3 Inhibitors in AML.

Catherine C. Smith. Use of FLT3 Inhibitors in AML. Clinical Lymphoma Myeloma & Leukemia. 2019 Sep 1; 19:s92-s94.

2019

https://researcherprofiles.org/profile/156853408

Catherine C. Smith

Search form